DUBLIN, March 5, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/ghwrtz/bolus_injectors) has announced the addition of the "Concise Analysis of the International Bolus Injectors Market, 2014 - 2024" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The injectable drug delivery market holds significant potential for the future. From conventional syringes with vials and painful needles to the modern-day pre-filled syringes, pen-injectors, needle free injectors and auto-injectors, the injectable drug delivery devices market has come a long way.
Taking the concept of self-injectors to a new stratum, Bolus Injectors' have surfaced recently. Also known as non-insulin patch pumps, these devices not only offer a range of benefits to the end users but also provide a number of additional benefits to other stakeholders in the industry.
One of the main drivers for the perceived growth of bolus injectors is the large number of biologics currently under development. A majority of these molecules are highly viscous and are required to be delivered in volumes of greater than 1 ml. The absence of devices which can safely administer these drugs is currently a big unmet need in the market. However, the early signs are encouraging. Despite the uncertainties related to the device development and approval, many companies are investing time, money and resources to develop novel devices.
Key Topics Covered:
1. Executive Summary
2. Introduction
3. Overview And Market Background
4. Target Drugs For Bolus Injectors
5. Product Profiles
6. Market Size And Forecast
7. Swot Analysis
8. Company Profiles
9. Interview Transcripts
10. Conclusion
11. Appendix 1: Tables
12. Appendix 2: List Of Companies
Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/ghwrtz/bolus_injectors
Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
Share this article